Investing Ideas
/
Bangladeshi Pharmaceuticals & Biotech Undervalued over 20% based on DCF

Bangladeshi Pharmaceuticals & Biotech Undervalued over 20% based on DCF

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

1 new

Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.

1 companies

Beximco Pharmaceuticals

Market Cap: ৳51.8b

Manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh.

New

BXPHARMA

৳116.10

8.6%

13.7%